Edigene Inc.

Edigene Inc.

Edigene Inc.

EdiGene is a biotechnology company with a mission to translate the cuttingedge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to advance drug discovery.
Type
B2b
Founded
2015
Raised
$82M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$67,000,000
Venture capital (Series B) - 2020
Kunlun Lilly Asia Ventures Sequoia Capital China +5
$15,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees
Location
Headquarters
$67,000,000 Venture capital (Series B)
DealStreetAsia

Chinese biotech firm EdiGene nabs $67m from Sequoia, IDG, others

$15,000,000 Venture capital (Series A)
FinSMEs

Genome Editing Biotech Company EdiGene Raises $15M in Series Pre-B Round

Funding Science